PRL and chronic kidney disease: However, additional large‐scale observational studies are needed to better determine the association of other circulating sex hormones, including free testosterone, estradiol, prolactin, DHEA‐S, and relaxin, with the risk of cardiovascular outcomes and mortality in the CKD population.